Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02460172
Other study ID # 006
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2015
Est. completion date February 15, 2017

Study information

Verified date February 2019
Source ZipLine Medical Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Study designed to compare the Zip Surgical Skin Closure device vs. conventional staples for wound closure following bi lateral knee replacement surgery.


Description:

Prospective, randomized, within patient control study comparing the use of Zip Surgical Skin Closure device versus conventional staple placement when utilized for surgical wound closure after bi lateral unicompartmental or bi lateral total knee replacement. A total of up to 25 patients will be enrolled and followed for up to 8 weeks post surgery to evaluate wound healing and overall satisfaction of closure method.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date February 15, 2017
Est. primary completion date February 15, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Patients 18 years of age and older

2. Patients requiring epidermal closure after bi lateral total or partial (unicompartmental) knee arthroplasty

3. Patients willing to be evaluated at discharge, 2 weeks, and at the 6 to 8 week post op

Exclusion Criteria:

1. Known bleeding disorder not caused by medication

2. Known personal or family history of keloid formation or scar hypertrophy

3. Known allergy or hypersensitivity to non-latex skin adhesives

4. Atrophic skin deemed clinically prone to blistering

5. Any skin disorder affecting wound healing

6. Any other condition that in the opinion of the investigator would make a particular patient unsuitable for this study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Zip Surgical Skin Closure
Non invasive, reversible, skin closure device for closure of the skin layer following surgical incisions or laceration repair.
Steel Staples
Skin closure device for the closure of the skin layer following surgical incision

Locations

Country Name City State
United States Shelbourne Knee Center Indianapolis Indiana

Sponsors (1)

Lead Sponsor Collaborator
ZipLine Medical Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incision Appearance / Scar Cosmesis Patient Scar Rating (0=Best to 10=Worst). A lower score means better scar rating.
Surgeon Scar Rating (0=Best to 10=Worst). A lower score means better scar rating.
Independent Plastic Surgeon Scar Rating by 8 week post op photos. (0=Best to 10=Worst). A lower score means better scar rating.
6-8 weeks post surgery
Secondary Surgeon Closure Method Satisfaction Closure method satisfaction will be collected by a 5 point satisfaction scale:
Very Satisfied
Satisfied
Neither
Dissatisfied
Very Dissatisfied A lower score means more satisfaction with the closure method.
6-8 weeks post op
Secondary Patient Pain - Incisional and General Pain levels will be collected using a 10 point VAS scale. Throughout 8 week study period (Discharge, 2 wk follow up and 8 wk exit visit)
Secondary Surgeon and Patient Scar Satisfaction Scar Satisfaction (both Zip and Staple sides) will be collected using a 5 point scale:
Very Satisfied Satisfied Neither Dissatisfied Very Dissatisfied
6 to 8 wk follow up visit
Secondary Range of Motion Knee Range of Motion for each knee will be measured in degrees 2 weeks and 6-8 weeks
See also
  Status Clinical Trial Phase
Completed NCT05045183 - A Study to Assess Wound Healing Efficacies of Different Clean, Treat, and Protect Wound Care Regimens Compared to Standard of Care and Untreated N/A
Enrolling by invitation NCT04613336 - Efficacy of Topical Heparin Spray on Donor Site Wound Healing Time Compared to Conventional Dressing Among Patients Undergoing Split Thickness Skin Grafting
Recruiting NCT02241811 - Wound Treatment With 3% Sodium Pentaborate Pentahydrate Phase 1
Completed NCT02797899 - Effect of PRF Palatal Bandage on Pain Scores and Wound Healing After Free Gingival Graft N/A
Completed NCT01227759 - Tyrosur® Gel-Investigation on Wound Healing Efficacy Phase 2
Completed NCT01061502 - Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds Phase 1/Phase 2
Completed NCT00736593 - A Study Evaluating Nexagon™ in the Treatment of Skin Wounds. Phase 1
Completed NCT00977951 - Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects Phase 1/Phase 2
Not yet recruiting NCT03872544 - Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Enrolling by invitation NCT03880188 - Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Recruiting NCT05191082 - Manufacturing, Characterization and Evaluation of the Effect of Silk Fibroin Membranes, Loaded or Not With Neurotensins on Open Wounds in the Palate N/A
Enrolling by invitation NCT05942235 - The Use of Microlearning in Nursing Education
Completed NCT03433820 - Wound Healing in Healthy Volunteers N/A
Withdrawn NCT02383992 - Postoperative Care of Sutured Wounds N/A
Recruiting NCT02034539 - VADOplex Critical Limb Ischemia Study Phase 2/Phase 3
Recruiting NCT01680042 - Clinical Effect of Phenytoin Mucoadhesive Paste on Wound Healing After Oral Biopsy Phase 1
Completed NCT01734317 - An Open Single-centre Investigation Evaluating Efficacy in Second Degree Partial Thickness Burns Using a Silicone Contact Layer Containing Silver. N/A
Completed NCT01115218 - The Influence of Anterior Chamber Fluid Mediators on the Success Rate of Trabeculectomy
Withdrawn NCT01008111 - Wound Healing of Incisional Wounds for Bilateral Hernia Repair Phase 1
Completed NCT00984503 - Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites Phase 2